Renfu Pharmaceutical announced that Yichang Renfu Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received a marketing license approval letter for midazolam injections approved and issued by the German Federal Drug and Medical Device Administration. After obtaining marketing approval from the German BfArM, midazolam injections can be sold in Germany, which will have a positive impact on the company's international business expansion.

Renfu Pharmaceutical announced that Yichang Renfu Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received a marketing license approval letter for midazolam injections approved and issued by the German Federal Drug and Medical Device Administration. After obtaining marketing approval from the German BfArM, midazolam injections can be sold in Germany, which will have a positive impact on the company's international business expansion.